You are here

Half of Cataract Surgery Patients Undergo Unnecessary Tests

Specialty societies give ‘thumbs down’ to low-benefit, high-cost preoperative testing

Despite guidelines in 2002 that advised against precautionary testing of patients before cataract surgery, which is considered to be a safe, quick procedure, 53% were referred for low-benefit and costly tests days before their operations, researchers have found.

A team at the University of California –San Francisco Medical Center conducted an analysis of more than 440,000 randomly sampled Medicare fee-for-service beneficiaries who had a cataract removed in 2011. Their findings were published April 15 in the New England Journal of Medicine.

“We know that routine preoperative testing doesn’t change outcomes in cataract surgery,” said study co-leader Catherine Chen, MD. “And we definitely think these physicians should not be ordering these tests unless their patients have some underlying medical condition, and even then they would have been worked up anyway, regardless of whether they are getting cataract surgery.”

The preoperative tests included blood, urine, chest, lung, or cardiac-function exams. Chen and her colleague R. Adams Dudley, MD, say that such testing can produce false alarms, which can lead to further testing and interventions.

Guidelines from multiple specialty societies, such as those representing cardiology, echocardiography, anesthesiology, and ophthalmology, have recommended against preoperative testing before cataract surgery, which lasts about 18 minutes and is routinely done using a topical anesthetic.

Dudley and Chen say their data show that about 36% of ophthalmologists ordered one preoperative test before cataract surgery for 75% of their patients and that 8% ordered at least one test for every one of their patients.

The researchers say that the lesson is an important one for policymakers going forward, because with the aging population, cataract surgeries will more than double from about 2 million today to 4.4 million in 2030, with Medicare paying 80% of those costs.

Chen and Dudley emphasize that they are not suggesting that doctors are referring their patients for pre-procedure testing to make money or to help their referral networks, although that might be happening in some settings.

Rather, Dudley says, the reason for all this testing is likely just a matter of habit, with old practice patterns proving tough for physicians to break.

When cataract surgeries became commonplace decades ago, they were perceived as much riskier, requiring general anesthesia, which can be problematic for people with heart problems or other co-morbidities. There was also concern that ophthalmologic surgeons would nick the eye, so they wanted patients to be completely immobilized, Chen says.

Now, she says, the technology and surgeons’ skills have improved to the extent that “they can now perform the procedure with a topical anesthetic,” such as lidocaine.

Another possible reason for the amount of preoperative blood and cardiac-function testing is that some of it might be unrelated to cataract surgery. For example, a Medicare beneficiary might be scheduling routine medical procedures, such as blood draws or urine tests, in close time proximity to her eye surgery, the authors say.

That, however, is unlikely because according to the data, the number of beneficiaries receiving tests in a given month remains steady for all other beneficiaries. But for those undergoing cataract surgery, the rate of these tests jumps dramatically in the 30 days prior to their procedures.

Another finding from the study is a sharp bump in office visits to primary-care or other non-ophthalmology or optometry doctors 30 days before surgery, another possible waste of time and spending, Dudley and Chen say.

That’s complicated by the fact that the Centers for Medicare & Medicaid Services and the Joint Commission both require that doctors take a medical history and do a physical exam within 30 days of any surgery. But that can be accomplished by the ophthalmologist just before cataract surgery, Dudley contends.

The study found that 52% of beneficiaries in 2011 had an office visit with another practitioner in the 30 days before their cataract procedure. Ophthalmologists might perform such exams prior to surgery, but many ophthalmologists “don't feel comfortable assessing the patient's other co-morbidities,” Chen says.

The message for ophthalmologists, professional societies, and policy makers alike is that an unnecessary referral for a medical workup just to assess the risk for a low-risk surgery, such as cataract removal, creates a setting for primary care and other doctors to order more tests and generate more false positives, Dudley says.

And unnecessary testing raises costs. According to the authors, for the 440,587 patients in the study, 798,150 tests were performed during the preoperative month at a cost of approximately $16.1 million. Another $28.3 million was spent on 308,397 office visits.

Those testing expenditures were $4.8 million higher, and the costs of office visits $12.4 million higher (42% and 78%, respectively), than the mean monthly expenditure during the preceding 11 months.

The authors’ cost estimates did not include beneficiary costs, costs paid by other insurers, or “downstream costs accruing because of follow-up of abnormal results from unnecessary tests.”

Chen stresses that cataract surgery today is extraordinarily safe. In the researchers’ analysis and in other studies, the mortality rate within the 7 days after cataract surgery for Medicare beneficiaries was only 1 per 100,000 surgeries.

“These pre-op tests have not been shown to prevent any adverse events or death in this patient population,” she says. “This type of routine testing is not indicated for patients if it’s being performed for the sole reason [that] they are scheduled for cataract surgery.”

Source: HealthLeaders Media; April 16, 2015.

Recent Headlines

Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks
Mortality nearly doubled when patients stopped using their drugs